antibacterial protease inhibitors (Medivir/University of London)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameantibacterial protease inhibitors (Medivir/University of London)
Drug Alias Nameantibacterials (Medivir/University of London)A-71561
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionProtease inhibitors
TargetsProtease
Therapy Area/IndicationsHelicobacter pylori infectionGingival DiseasesStaphylococcal Infections +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMedivir AB
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedivir ABUniversity Of London
Active IndicationsN/A
Inactive IndicationsHelicobacter pylori infectionGingival DiseasesStaphylococcal Infections +[5] 

Other Information

ATC CodeN/A
Related LinksN/A